$64.23
1.46[2.33%]
At close: Apr 23
$64.23
0[0.00%]
After Hours: 4:00PM EDT
LeMaitre Vascular
(NASDAQ:LMAT)LeMaitre Vascular Stock (NASDAQ:LMAT), Analyst Ratings, Price Targets, Predictions
LeMaitre Vascular Inc has a consensus price target of $56.75, established from looking at the 12 latest analyst ratings. The last 3 analyst ratings were released from Barrington Research, Keybanc, and JMP Securities on February 28, 2024, February 6, 2024, and October 23, 2023. With an average price target of $43 between Barrington Research, Keybanc, and JMP Securities, there's an implied -33.05% downside for LeMaitre Vascular Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Barrington Research
Keybanc
JMP Securities
Oppenheimer
Jefferies
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for LeMaitre Vascular
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/28/2024 | LMAT | Buy Now | LeMaitre Vascular | $64.23 | 7.43% | Barrington Research | Michael Petusky | $66 → $69 | Maintains | Outperform | Get Alert |
| 02/06/2024 | LMAT | Buy Now | LeMaitre Vascular | $64.23 | — | Keybanc | Brett Fishbin | — | Initiates | → Sector Weight | Get Alert |
| 10/23/2023 | LMAT | Buy Now | LeMaitre Vascular | $64.23 | -6.59% | JMP Securities | Daniel Stauder | → $60 | Initiates | → Market Outperform | Get Alert |
| 09/06/2023 | LMAT | Buy Now | LeMaitre Vascular | $64.23 | 8.98% | Oppenheimer | Suraj Kalia | → $70 | Initiates | → Outperform | Get Alert |
| 08/03/2023 | LMAT | Buy Now | LeMaitre Vascular | $64.23 | 4.31% | Jefferies | Anthony Petrone | $63 → $67 | Downgrade | Buy → Hold | Get Alert |
| 08/02/2023 | LMAT | Buy Now | LeMaitre Vascular | $64.23 | 16.77% | Lake Street | Brooks O'Neil | $65 → $75 | Maintains | Buy | Get Alert |
| 08/02/2023 | LMAT | Buy Now | LeMaitre Vascular | $64.23 | 2.76% | Barrington Research | Michael Petusky | $62 → $66 | Maintains | Outperform | Get Alert |
| 05/03/2023 | LMAT | Buy Now | LeMaitre Vascular | $64.23 | -3.47% | Barrington Research | Michael Petusky | → $62 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/28/2022 | LMAT | Buy Now | LeMaitre Vascular | $64.23 | — | Barrington Research | Michael Petusky | — | Downgrade | Outperform → Market Perform | Get Alert |
| 09/16/2021 | LMAT | Buy Now | LeMaitre Vascular | $64.23 | 8.98% | Jefferies | Anthony Petrone | — | Initiates | → Buy | Get Alert |
| 08/03/2021 | LMAT | Buy Now | LeMaitre Vascular | $64.23 | -9.7% | Roth Capital | Scott Henry | — | Maintains | Neutral | Get Alert |
| 05/04/2021 | LMAT | Buy Now | LeMaitre Vascular | $64.23 | -14.37% | Roth Capital | — | — | Maintains | Neutral | Get Alert |
FAQ
What is the target price for LeMaitre Vascular (LMAT)?
The latest price target for LeMaitre Vascular (NASDAQ: LMAT) was reported by Barrington Research on February 28, 2024. The analyst firm set a price target for $69.00 expecting LMAT to rise to within 12 months (a possible 7.43% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for LeMaitre Vascular (LMAT)?
The latest analyst rating for LeMaitre Vascular (NASDAQ: LMAT) was provided by Barrington Research, and LeMaitre Vascular maintained their outperform rating.
When was the last upgrade for LeMaitre Vascular (LMAT)?
The last upgrade for LeMaitre Vascular Inc happened on May 3, 2023 when Barrington Research raised their price target to $62. Barrington Research previously had a market perform for LeMaitre Vascular Inc.
When was the last downgrade for LeMaitre Vascular (LMAT)?
The last downgrade for LeMaitre Vascular Inc happened on August 3, 2023 when Jefferies changed their price target from $63 to $67 for LeMaitre Vascular Inc.
When is the next analyst rating going to be posted or updated for LeMaitre Vascular (LMAT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LeMaitre Vascular, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LeMaitre Vascular was filed on February 28, 2024 so you should expect the next rating to be made available sometime around February 28, 2025.
Is the Analyst Rating LeMaitre Vascular (LMAT) correct?
While ratings are subjective and will change, the latest LeMaitre Vascular (LMAT) rating was a maintained with a price target of $66.00 to $69.00. The current price LeMaitre Vascular (LMAT) is trading at is $64.23, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.